Test Price
20,000 AED✅ Home Collection Available
ddRAD Sequencing Primary Data Analysis (96 Samples) in UAE – 20,000 AED – DHA Licensed Genomics
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited processing and validated bioinformatics pipeline.
- Premium Logistics: VIP Mobile Phlebotomy and temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic post-test consultation with a DHA-licensed Consultant Medical Geneticist.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
- Batch Scale: 96-sample parallel processing delivering population-scale SNP discovery at a per-sample cost of ~208 AED.
Test Overview & Methodology
ddRAD (double digest Restriction-site Associated DNA) sequencing is a reduced-representation genomic profiling method that simultaneously detects single nucleotide polymorphisms (SNPs) and structural variants across 96 samples in a single batch. This test delivers comprehensive primary data analysis — including FASTQ files, quality control metrics, sequence alignment, and variant calling — using an Illumina NovaSeq platform operating within our DHA-licensed facility. The output empowers oncologists, rheumatologists, and genomic researchers with high-resolution genetic insights for population studies, cancer susceptibility profiling, and autoimmune disorder panels.
| Feature | Our ddRAD Sequencing (96-Sample Batch) | Whole-Genome Sequencing (30×) |
|---|---|---|
| Diagnostic Precision | 99.9% SNP call accuracy via validated bioinformatics pipeline | 99.5% typical (higher false-positive rate in repetitive regions) |
| Methodology | Double-digest RE-based enrichment + Illumina NovaSeq + custom primary analysis | Shotgun library prep + NovaSeq + standard GATK pipeline |
| Turnaround Time | 4 weeks | 6–8 weeks |
| Price per Sample (AED) | ~208 AED (20,000 AED total for 96 samples) | ~3,000–5,000 AED |
| Clinical Application | Population-scale SNP discovery, cancer susceptibility, autoimmune disorder panels | Whole-genome rare variant discovery, comprehensive germline testing |
Physician Insight & Safety Protocols
“As a Consultant Medical Geneticist, I emphasize that ddRAD sequencing data provide research-grade genetic markers and must always be interpreted alongside the patient’s complete medical history, physical examination, and other laboratory findings. This test is a powerful tool for identifying susceptibility variants, but it is not a standalone diagnostic and should never replace a face-to-face specialist consultation. All variant calls require confirmation through orthogonal methods before any clinical action is taken.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory Notice
⚠️ Important Clinical Advisory: ddRAD sequencing results are intended for research and clinical decision support. Do not discontinue or modify any prescribed medication based solely on these genetic findings without consulting your treating physician. This test does not provide immediate therapeutic recommendations and must be correlated with comprehensive clinical evaluation.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Patients with acute systemic infection, active bleeding disorder, inability to provide informed consent, or uncooperative for venipuncture. This test is not validated for minors without explicit genetic counseling and parental consent under UAE Federal Decree-Law No. 4 of 2016 on Medical Liability.
- ER Red Flags: If during home collection you experience severe pain, sudden swelling, difficulty breathing, or signs of anaphylaxis, call 998 (UAE Ambulance) immediately.
- Pediatric Exclusion: ddRAD sequencing is not validated for individuals under 18 years without prior genetic counseling and explicit informed consent from a legal guardian.
Patient FAQ & Clinical Guidance
1. What is the clinical utility of ddRAD sequencing for cancer patients?
ddRAD sequencing provides a cost-effective genome-wide SNP analysis for cancer susceptibility gene discovery and monitoring. By profiling 96 samples in parallel, it allows oncologists to detect inherited risk alleles and track somatic evolution when paired with tumour tissue. The primary analysis report includes annotated variant call files (VCF) that can be directly loaded into clinical decision support systems. All results must be reviewed by a medical geneticist before any clinical action is taken.
2. How long does it take to receive the ddRAD sequencing results?
Our ISO-accredited laboratory delivers primary data analysis within 4 weeks from sample receipt. This turnaround time includes DNA extraction, library preparation, sequencing, and bioinformatic processing. Urgent requests can be expedited after consultation with our medical director; however, quality control steps are never compromised. Digital reports are shared via a secure HIPAA-compliant portal, and you will receive a notification on WhatsApp as soon as your data are ready.
3. Is home sample collection available in Dubai and Abu Dhabi?
Yes, we provide hospital-grade home blood collection via DHA-licensed mobile phlebotomists across all Emirates. Service operates daily from 8 AM to 11 PM, including weekends. Our team carries ISO-certified cold-chain transport boxes and adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL). Simply book through WhatsApp +971 54 548 8731 and we will arrive at your doorstep within 60 minutes in Dubai and Abu Dhabi city limits.
4. What type of sample is required for ddRAD sequencing?
A standard peripheral whole blood sample (3–5 mL collected in an EDTA tube) is required for DNA extraction. Buccal swab samples are accepted only after prior consultation with our laboratory team. The sample must be collected using sterile, DNAse-free equipment and transported under temperature-controlled conditions to preserve nucleic acid integrity.
5. Can ddRAD sequencing replace whole-genome sequencing?
No, ddRAD sequencing is a reduced-representation method that targets a subset of the genome, making it cost-effective for population-scale SNP discovery and targeted variant screening. Whole-genome sequencing provides broader coverage for rare variant discovery but at a significantly higher cost. The choice between the two methods depends on the specific clinical or research question, and should be guided by a medical geneticist.
UAE Regulatory & Data Privacy Adherence
- All patient data are processed under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Clinical safety, patient consent, and medical liability adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
- ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139) — facility license No. 1143.
- A fully DHA-licensed medical laboratory; all results are supervised by DHA-licensed Consultant Medical Geneticist Lina Osama Zaki Quteineh (DHA Registration ID: 9294403).
- All genetic data are stored and transmitted using AES-256 encryption and access-controlled systems compliant with international genomic data protection standards.
Clinical & Logistical Metadata
| Test Name | ddRAD Sequencing Primary Data Analysis (96 Samples) |
| Price (AED) | 20,000 AED (approx. 208 AED per sample) |
| Turnaround Time | 4 weeks from sample receipt |
| Sample Type / Matrix | Peripheral whole blood (EDTA tube) or buccal swab (saliva) |
| Methodology Used | Double-digest Restriction-site Associated DNA (ddRAD) sequencing on Illumina NovaSeq platform with custom bioinformatics pipeline for primary analysis (FASTQ, QC, alignment, variant calling) |
| ICD-10-CM Code | Z13.89 (Encounter for screening for other disorder) |
| LOINC Code | 81267-3 (Genetic analysis report) |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | DNA Labs UAE | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians